Patent · US Active

PSMA imaging agents

US10011632B2 · kind B2 · utility

5Cited by
0References
39Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 21, 2012
Grant dateJul 3, 2018
Priority date
Expiry dateJan 8, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds for targeting and agents for imaging, Prostate-specific membrane antigen (PSMA) are disclosed. Methods of synthesizing compounds and imaging agents, as well as methods for imaging PSMA are also disclosed. The imaging agents disclosed are suitable for PET and SPECT imaging.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.